Skip to main content
Have a personal or library account? Click to login
Serum TNF-α and IL-8 as predictors of gastric mucosal cancerization in Helicobacter pylori-positive gastritis Cover

Serum TNF-α and IL-8 as predictors of gastric mucosal cancerization in Helicobacter pylori-positive gastritis

By: Zhuoyu Peng,  Xuelian Yang,  Min Li,  Di Wan and  Juju Liu  
Open Access
|Apr 2026

References

  1. Elghannam MT, Hassanien MH, Ameen YA, Turky EA, ELattar GM, ELRay AA, et al. Helicobacter pylori and oral-gut microbiome: clinical implications. Infection. 2024;52(2):289-300. DOI: 10.1007/s15010-023-02115-7
  2. Koch MRA, Gong R, Friedrich V, Engelsberger V, Kretschmer L, Wanisch A, et al. CagA-specific Gastric CD8+ Tissue-Resident T Cells Control Helicobacter pylori During the Early Infection Phase. Gastroenterology. 2023;164(4):550-66. DOI: 10.1053/j. gastro.2022.12.016
  3. Xia T, Zhang Z, Xie J, Yuan H, Ren Y, Xu Y, et al. Gastric mucosal CD8+TRM cells are recruited through CXCR5-CXCL13 axis in Helicobacter pylori infected subjects. Cytokine. 2025;190:156904. DOI: 10.1016/j.cyto.2025.156904
  4. Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci. 2021;22(5):2719. DOI: 10.3390/ijms22052719
  5. Liu H, Zhao Q, Tan L, Wu X, Huang R, Zuo Y, et al. Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma. Cancer Cell. 2023;41(4):693-710.e8. DOI: 10.1016/j. ccell.2023.03.004
  6. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161-81. DOI: 10.1097/00000478-199610000-00001
  7. Yu B, Xiang L, Peppelenbosch MP, Fuhler GM. Overlapping cytokines in H. pylori infection and gastric cancer: A tandem meta-analysis. Front Immunol. 2023;14:1125658. DOI: 10.3389/fimmu.2023.1125658
  8. Wang H, Zhao M, Shi F, Zheng S, Xiong L, Zheng L. A review of signal pathway induced by virulent protein CagA of Helicobacter pylori. Front Cell Infect Microbiol. 2023;13:1062803. DOI: 10.3389/fcimb.2023.1062803
  9. Dolcetti E, Bruno A, Azzolini F, Gilio L, Pavone L, Iezzi E, et al. Genetic regulation of IL-8 influences disease presentation of multiple sclerosis. Mult Scler. 2023;29(4-5):512-20. DOI: 10.1177/13524585231155049
  10. Domínguez-Martínez DA, Fontes-Lemus JI, García-Regalado A, Juárez-Flores Á, Fuentes-Pananá EM. IL-8 Secreted by Gastric Epithelial Cells Infected with Helicobacter pylori CagA Positive Strains Is a Chemoattractant for Epstein-Barr Virus Infected B Lymphocytes. Viruses. 2023;15(3):651. DOI: 10.3390/v15030651
  11. Yuan W, Shi Y, Dai S, Deng M, Zhu K, Xu Y, et al. The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects. J Transl Med. 2024;22(1):1142. DOI: 10.1186/s12967-024-05998-8
  12. Wu X, Meng W, Duan C, Cao J, Wei Y, Cui X, et al. AFG1-induced TNF-α-mediated inflammation enhances gastric epithelial cell injury via CYP2E1. Food Chem Toxicol. 2023;176:113756. DOI: 10.1016/j.fct.2023.113756
  13. Zhang S, Shen Y, Liu H, Zhu D, Fang J, Pan H, et al. Inflammatory microenvironment in gastric premalignant lesions: implication and application. Front Immunol. 2023;14:1297101. DOI: 10.3389/fimmu.2023.1297101
  14. Ma Y, Fu Y, Fan X, Ji Q, Duan X, Wang Y, et al. FAK/IL-8 axis promotes the proliferation and migration of gastric cancer cells. Gastric Cancer. 2023;26(4):528-41. DOI: 10.1007/s10120-023-01384-3
  15. Takahashi-Kanemitsu A, Lu M, Knight CT, Yamamoto T, Hayashi T, Mii Y, et al. The Helicobacter pylori CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyloric gland base cells. Sci Signal. 2023;16(794):eabp9020. DOI: 10.1126/scisignal.abp9020
  16. Hou Y, Li X, Yang Y, Shi H, Wang S, Gao M. Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer. Front Immunol. 2023;14:1274431. DOI: 10.3389/fimmu.2023.1274431
  17. Rosu MC, Tarta C, Moldovan S, Neamtu AA, Ardelean A, Capitanio M, et al. Integrating TNF-α with Established Tumor Markers to Enhance Prognostic Accuracy in Gastric Cancer: A Prospective Observational Study. Biomedicines. 2025;13(4):928. DOI: 10.3390/biomedicines13040928
  18. Reyes ME, Pulgar V, Vivallo C, Ili CG, Mora-Lagos B, Brebi P. Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance. Front Immunol. 2024;15:1347530. DOI: 10.3389/fimmu.2024.1347530
  19. Matsuoka T, Yashiro M. Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment. Int J Mol Sci. 2024;25(21):11735. DOI: 10.3390/ijms252111735
  20. Li X, Peng J, Su X. Expression of immune regulatory factors, chemokines and growth factors in differentiated gastric cancer cells treated with an anticancer bioactive peptide combined with oxaliplatin. Mol Clin Oncol. 2023;20(1):9. DOI: 10.3892/mco.2023.2707
DOI: https://doi.org/10.2478/rrlm-2026-0007 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 143 - 150
Submitted on: Jun 20, 2025
Accepted on: Jan 13, 2026
Published on: Apr 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Zhuoyu Peng, Xuelian Yang, Min Li, Di Wan, Juju Liu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.